Other GLP-1 receptor agonists or different medication classes may be suitable, depending on your individual circumstances and whether cross-reactivity is a concern
Mounjaro lawsuits allege that some users developed gastroparesis, stomach paralysis, intestinal obstruction, severe vomiting, dehydration, malnutrition, kidney injury related to fluid loss, and other digestive complications after using the drug
For example, if you normally inject Wednesday but forgot until Friday, inject Friday
The FDA has not yet mandated black-box warnings
Most providers recommend staying on a stable dose of Ozempic before adding topiramate to help distinguish which medication is causing specific side effects
In contrast to tirzepatide, maridebart cafraglutide is a long-acting peptideantibody conjugate that combines GLP-1 agonism with GIP antagonism